Clinical Trials Browser

Phase NA × Pemetrexed × Clear all

NCT02194738 2026-05-13

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Phase NA Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07538193 2026-04-20

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Phase NA Not yet recruiting

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

NCT06484491 2026-01-30

HyDose

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06576635 2026-01-20

LUNG-05

Phase NA Recruiting

NSCLC

NCT06304441 2025-09-29

Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer

Phase NA Recruiting

Meningeal Carcinomatosis

NCT06643000 2025-03-06

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06649448 2024-10-18

EF-001

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

NCT04552613 2024-01-16

Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients

Phase NA Completed

Carcinoma, Non-Small-Cell Lung

NCT05527808 2023-06-08

A Single-arm Exploratory Study of Neoadjuvant Therapy

Phase NA Unknown

Adenocarcinoma of Lung

NCT05305885 2022-09-30

Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis

Phase NA Unknown

Meningeal Carcinomatosis

NCT02145078 2020-09-24

Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer

Phase NA Terminated

4 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT01063283 2019-11-18

AVF4759

Phase NA Completed

20 enrolled 9 charts

Advanced Non-squamous Non-Small Cell Lung Cancer

NCT03671538 2018-09-17

Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin

Phase NA Unknown

Non-squamous Non-small Cell Lung Cancer

NCT03566576 2018-06-25

Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel

Phase NA Unknown

Non-squamous Non-small Cell Lung Cancer

NCT03489616 2018-04-05

CRAGMOLC

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT02148380 2016-04-20

Combination of Chemotherapy and Gefitinib as First-line Treatment

Phase NA Completed

Carcinoma, Non-Small-Cell Lung

NCT01209520 2015-02-24

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Phase NA Completed

6 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinogenesis

NCT01860508 2013-07-08

A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT01004601 2009-10-30

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

Phase NA Completed

Carcinoma, Non-Small-Cell Lung

NCT00903292 2009-05-18

Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung